Researchers have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer (PCa), according to study findings published online in The Lancet ...
About 25%-33% of men with prostate cancer (PCa) will experience a recurrence of their cancer after primary radiation therapy. Among the various salvage treatments available is salvage radical ...
Treatment outcomes for metastatic castration-resistant prostate cancer (mCRPC) following progression on upfront androgen deprivation therapy (ADT) with androgen receptor pathway inhibitors (ARPI) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results